Avego Bioscience Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is CellCentric's $220M Series B+ round in May 2026, alongside Venrock Healthcare Capital Partners, Sofinnova Partners, RA Capital Management and 5 others. That company is in Health and bio.

What Avego Bioscience Capital invests in

• Health and bio · 1 · 100%

How Avego Bioscience Capital invests

Share is of the 1 round on Recent Funding that name Avego Bioscience Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Avego Bioscience Capital portfolio companies

• CCellCentric$220MSeries B+ · May 2026

Most frequent co-investors

• FFidelity1 shared round · last May 6, 2026
• RRA Capital Management1 shared round · last May 6, 2026
• BBrightEdge - American Cancer Society1 shared round · last May 6, 2026
• SSofinnova Partners1 shared round · last May 6, 2026
• FForbion Capital Partners1 shared round · last May 6, 2026
• VVenrock Healthcare Capital Partners1 shared round · last May 6, 2026
• PPfizer1 shared round · last May 6, 2026
• HHBM Healthcare Investments1 shared round · last May 6, 2026

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• DDeepWork Capital1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Avego Bioscience Capital, which is a subset of its real portfolio. API: /api/v1/investors/avego-bioscience-capital (get a free API key). More: the most active VC firms and new venture capital funds.